Cargando…

Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects

Curative surgical treatments, mainly liver resection, are still one of the optimal options for patients with early-, mid-, and even progression-stage hepatocellular carcinoma (HCC). However, the recurrence rate within 5 years after surgery is as high as 70%, especially in patients with high risk fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Bin, Chen, Qian, Liu, Zhicheng, Chen, Xiaoping, Zhu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149944/
https://www.ncbi.nlm.nih.gov/pubmed/37139151
http://dx.doi.org/10.3389/fonc.2023.1098958